Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Fell Below 20 DMA | Bearish | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Crossed Above 20 DMA | Bullish | -4.44% | |
Earnings Movers | Other | -4.44% | |
Wide Bands | Range Expansion | -4.44% | |
Gapped Down | Weakness | -4.44% | |
Fell Below 20 DMA | Bearish | 1.78% |
Alert | Time |
---|---|
20 DMA Resistance | about 6 hours ago |
Fell Below 20 DMA | about 6 hours ago |
10 DMA Resistance | about 7 hours ago |
50 DMA Resistance | about 10 hours ago |
Gap Down Partially Closed | about 11 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/14/2024
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.2565 |
52 Week Low | 1.0701 |
Average Volume | 17,753 |
200-Day Moving Average | 2.69 |
50-Day Moving Average | 3.62 |
20-Day Moving Average | 3.48 |
10-Day Moving Average | 3.55 |
Average True Range | 0.33 |
RSI (14) | 47.64 |
ADX | 22.99 |
+DI | 29.78 |
-DI | 20.25 |
Chandelier Exit (Long, 3 ATRs) | 3.50 |
Chandelier Exit (Short, 3 ATRs) | 3.74 |
Upper Bollinger Bands | 4.24 |
Lower Bollinger Band | 2.73 |
Percent B (%b) | 0.47 |
BandWidth | 43.53 |
MACD Line | 0.00 |
MACD Signal Line | 0.02 |
MACD Histogram | -0.0201 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.01 | ||||
Resistance 3 (R3) | 4.06 | 3.92 | 3.92 | ||
Resistance 2 (R2) | 3.92 | 3.77 | 3.90 | 3.88 | |
Resistance 1 (R1) | 3.68 | 3.69 | 3.80 | 3.63 | 3.85 |
Pivot Point | 3.54 | 3.54 | 3.60 | 3.52 | 3.54 |
Support 1 (S1) | 3.30 | 3.39 | 3.42 | 3.25 | 3.03 |
Support 2 (S2) | 3.16 | 3.31 | 3.14 | 3.00 | |
Support 3 (S3) | 2.92 | 3.16 | 2.97 | ||
Support 4 (S4) | 2.87 |